PPARG and obesity due to melanocortin 4 receptor deficiency: While reduced mitochondrial functions or heightened oxidative stress may offer plausible explanations for the exacerbated obesity‐specific DILI observed with certain drugs, acknowledging the emergence of novel mechanisms, such as the additional hepatic activation of PPARγ by TZDs or BBR, is equally crucial.